Physician profile
Sharon B Mitchell
NPI 1306806930
$943.75
in general payments reported to CMS, 2019-2025
17 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $251 · 2021: $63.59 · 2022: $42.60 · 2023: $77.59 · 2024: $78.43 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $310.01 | 2019-2025 | Farxiga |
| Stemline Therapeutics INC. | $125.00 | 2025 | Orserdu |
| Novo Nordisk INC | $121.78 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $55.12 | 2025 | |
| Sunovion Pharmaceuticals INC. | $53.64 | 2019 | |
| Amgen INC. | $46.20 | 2019-2024 | Evenity, Prolia |
| Abbott Laboratories | $43.75 | 2025 | Freestyle Libre 3 |
| Mylan Specialty L.P. | $28.14 | 2022 | |
| Corcept Therapeutics | $25.44 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.69 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.95 | 2023 | Synjardy, Jardiance |
| Athena Bioscience, LLC | $19.18 | 2024 | Nexiclon Xr |
| Exact Sciences Corporation | $18.21 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.80 | 2023 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $13.96 | 2024 | Voquezna |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.